Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


07.11.2022

4 Alzheimers Dement
1 Am J Alzheimers Dis Other Demen
1 Brain
1 Brain Res
16 J Alzheimers Dis
2 J Biol Chem
1 J Clin Psychiatry
2 J Neurochem
1 Nat Neurosci
4 Nat Rev Neurol
1 Neurobiol Dis
1 Neurochem Res
1 Neurology
1 Neuropsychology
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Alzheimers Dement

  1. GILLIS C, Montenigro P, Nejati M, Maserejian N, et al
    Estimating prevalence of early Alzheimer's disease in the United States, accounting for racial and ethnic diversity.
    Alzheimers Dement. 2022 Nov 2. doi: 10.1002/alz.12822.
    PubMed         Abstract available

  2. KYLE S, Youran T, Thomas W, Liuhua S, et al
    The effect of race and co-morbidities on Alzheimer's disease based on Medicare data.
    Alzheimers Dement. 2022 Nov 3. doi: 10.1002/alz.12838.
    PubMed         Abstract available


  3. Alzheimer's Association takes on leadership role in landmark Alzheimer's biomarker study.
    Alzheimers Dement. 2022 Nov 4. doi: 10.1002/alz.12873.
    PubMed        

  4. ZHANG P, Hou Y, Tu W, Campbell N, et al
    Population-based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans.
    Alzheimers Dement. 2022 Nov 4. doi: 10.1002/alz.12819.
    PubMed         Abstract available


    Am J Alzheimers Dis Other Demen

  5. STANZANI MASERATI M, Matacena M, Baccari F, Zenesini C, et al
    The Tree Drawing Test in Evolution: An Explorative Longitudinal Study in Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2022;37:15333175221129381.
    PubMed         Abstract available


    Brain

  6. SEYEDSALEHI A, Warrier V, Bethlehem RAI, Perry BI, et al
    Educational attainment, structural brain reserve and Alzheimer's disease: a Mendelian randomization analysis.
    Brain. 2022 Oct 31. pii: 6780317. doi: 10.1093.
    PubMed         Abstract available


    Brain Res

  7. ANSARI MA, Rao MS, Al-Jarallah A, Babiker FM, et al
    Early Time Course of Oxidative Stress in Hippocampal Synaptosomes and Cognitive Loss Following Impaired Insulin Signaling in Rats: Development of Sporadic Alzheimer's Disease.
    Brain Res. 2022 Oct 31:148134. doi: 10.1016/j.brainres.2022.148134.
    PubMed         Abstract available


    J Alzheimers Dis

  8. CHAUDHARY S, Zhornitsky S, Chao HH, van Dyck CH, et al
    Hypothalamic Functional Connectivity and Apathy in People with Alzheimer's Disease and Cognitively Normal Healthy Controls.
    J Alzheimers Dis. 2022 Oct 22. pii: JAD220708. doi: 10.3233/JAD-220708.
    PubMed         Abstract available

  9. DISSANAYAKE AS, Tan YB, Bowie CR, Butters MA, et al
    Sex Modifies the Associations of APOEvarepsilon4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 25. pii: JAD220586. doi: 10.3233/JAD-220586.
    PubMed         Abstract available

  10. GAITAN JM, Asthana S, Carlsson CM, Engelman CD, et al
    Circulating Klotho Is Higher in Cerebrospinal Fluid than Serum and Elevated Among KLOTHO Heterozygotes in a Cohort with Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 22. pii: JAD220571. doi: 10.3233/JAD-220571.
    PubMed         Abstract available

  11. MA Y, Li W, Fan C, Wang Y, et al
    Comprehensive Analysis of Long Non-Coding RNAs N4-Acetylcytidine in Alzheimer's Disease Mice Model Using High-Throughput Sequencing.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD220564. doi: 10.3233/JAD-220564.
    PubMed         Abstract available

  12. LACHNER C, Day GS, Camsari GB, Kouri N, et al
    Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old.
    J Alzheimers Dis. 2022;90:405-417.
    PubMed         Abstract available

  13. MATTIOLI P, Pardini M, Girtler N, Brugnolo A, et al
    Cognitive and Brain Metabolism Profiles of Mild Cognitive Impairment in Prodromal Alpha-Synucleinopathy.
    J Alzheimers Dis. 2022;90:433-444.
    PubMed         Abstract available

  14. LOEWENSTEIN DA, Curiel Cid RE, Kitaigorodsky M, Ortega A, et al
    Persistent Failure to Recover from Proactive Semantic Interference on the Cognitive Stress Test Differentiates Between Amnestic Mild Cognitive Impairment, Pre-Mild Cognitive Impairment, and Cognitively Unimpaired Older Adults.
    J Alzheimers Dis. 2022;90:313-322.
    PubMed         Abstract available

  15. THOMAS KR, Bangen KJ, Weigand AJ, Ortiz G, et al
    Cognitive Heterogeneity and Risk of Progression in Data-Driven Subtle Cognitive Decline Phenotypes.
    J Alzheimers Dis. 2022;90:323-331.
    PubMed         Abstract available

  16. FU J, Zhu Y, Sun Y, Liu Q, et al
    Circulating Amyloid-beta and Methionine-Related Metabolites to Predict the Risk of Mild Cognitive Impairment: A Nested Case-Control Study.
    J Alzheimers Dis. 2022;90:389-404.
    PubMed         Abstract available

  17. VAN HARTEN TW, Heijmans A, van Rooden S, Wermer MJH, et al
    Brain Deep Medullary Veins on 7T MRI in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;90:381-388.
    PubMed         Abstract available

  18. BOLSEWIG K, Hok-A-Hin YS, Sepe FN, Boonkamp L, et al
    A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.
    J Alzheimers Dis. 2022;90:363-380.
    PubMed         Abstract available

  19. WEI S, Dang L, Gao F, Wang J, et al
    Effects of Simvastatin on Plasma Amyloid-beta Transport in Patients with Hyperlipidemia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial.
    J Alzheimers Dis. 2022;90:349-362.
    PubMed         Abstract available

  20. PENG Y, Zhang L, Zhou F, Wang Y, et al
    Scavenging Reactive Oxygen Species Decreases Amyloid-beta Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells.
    J Alzheimers Dis. 2022;90:185-198.
    PubMed         Abstract available

  21. GAO F, Zhang PF, Gao J, Song J, et al
    The CCL2 rs4586 SNP Is Associated with Slower Amyloid-beta Deposition and Faster Tau Accumulation of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD220716. doi: 10.3233/JAD-220716.
    PubMed         Abstract available

  22. GOLZARI-SORKHEH M, Weaver DF, Reed MA
    COVID-19 as a Risk Factor for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD220800. doi: 10.3233/JAD-220800.
    PubMed         Abstract available

  23. SCHAFFERT J, Bue CL, Hynan LS, Hart J, et al
    Erratum to: Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD229015. doi: 10.3233/JAD-229015.
    PubMed        


    J Biol Chem

  24. KENYAGA JM, Cheng Q, Qiang W
    Early stage beta-amyloid-membrane interactions modulate lipid dynamics and influence structural interfaces and fibrillation.
    J Biol Chem. 2022;298:102491.
    PubMed         Abstract available

  25. IQBAL J, Suarez MD, Yadav PK, Walsh MT, et al
    ATP-binding cassette protein ABCA7 deficiency impairs sphingomyelin synthesis, cognitive discrimination, and synaptic plasticity in the entorhinal cortex.
    J Biol Chem. 2022;298:102411.
    PubMed         Abstract available


    J Clin Psychiatry

  26. ICHO S, Korten N, Reus L, Belderok T, et al
    Relationship Between Sporadic Behavioral Variant Frontotemporal Dementia and Primary Psychiatric Disorders: A Study in Families.
    J Clin Psychiatry. 2022;83.
    PubMed         Abstract available


    J Neurochem

  27. SEPULVEDA J, Luo N, Nelson M, Ng CAS, et al
    Independent APOE4 knock-in mouse models display reduced brain APOE protein, altered neuroinflammation, and simplification of dendritic spines.
    J Neurochem. 2022;163:247-259.
    PubMed         Abstract available

  28. GARCIA-SEGURA ME, Durainayagam BR, Liggi S, Graca G, et al
    Pathway-based integration of multi-omics data reveals lipidomics alterations validated in an Alzheimer s Disease mouse model and risk loci carriers.
    J Neurochem. 2022 Nov 3. doi: 10.1111/jnc.15719.
    PubMed         Abstract available


    Nat Neurosci

  29. LENG K, Rose IVL, Kim H, Xia W, et al
    CRISPRi screens in human iPSC-derived astrocytes elucidate regulators of distinct inflammatory reactive states.
    Nat Neurosci. 2022;25:1528-1542.
    PubMed         Abstract available


    Nat Rev Neurol

  30. WOOD H
    Tau - the missing link between chronic pain and dementia?
    Nat Rev Neurol. 2022 Sep 16. pii: 10.1038/s41582-022-00725.
    PubMed        

  31. CREESE B, Lunnon K
    Neuropsychiatric symptoms in AD: the search for mechanisms.
    Nat Rev Neurol. 2022;18:639-640.
    PubMed        

  32. LEMPRIERE S
    Engineered TREM2 antibody clears Abeta in mice.
    Nat Rev Neurol. 2022;18:637.
    PubMed        

  33. BRENOWITZ WD, Yaffe K
    Observational studies in Alzheimer disease: bridging preclinical studies and clinical trials.
    Nat Rev Neurol. 2022 Oct 31. pii: 10.1038/s41582-022-00733.
    PubMed         Abstract available


    Neurobiol Dis

  34. SARKAR S
    Microglial ion channels: Key players in non-cell autonomous neurodegeneration.
    Neurobiol Dis. 2022;174:105861.
    PubMed         Abstract available


    Neurochem Res

  35. WU Y, Hang Z, Lei T, Du H, et al
    Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones.
    Neurochem Res. 2022 Oct 30. pii: 10.1007/s11064-022-03784.
    PubMed         Abstract available


    Neurology

  36. GHAHREMANI M, Wang M, Chen HY, Zetterberg H, et al
    Plasma P-Tau181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease.
    Neurology. 2022 Nov 2. pii: WNL.0000000000201517.
    PubMed         Abstract available


    Neuropsychology

  37. WEBBER TA, Kiselica AM, Mikula C, Woods SP, et al
    Dispersion-based cognitive intra-individual variability in dementia with Lewy bodies.
    Neuropsychology. 2022;36:719-729.
    PubMed         Abstract available


    PLoS One

  38. KANNAPPAN B, Te Nijenhuis J, Choi YY, Lee JJ, et al
    Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer's disease?
    PLoS One. 2022;17:e0275233.
    PubMed         Abstract available

  39. NASIRI M, Moayedfar S, Purmohammad M, Ghasisin L, et al
    Investigating sentence processing and working memory in patients with mild Alzheimer and elderly people.
    PLoS One. 2022;17:e0266552.
    PubMed         Abstract available

  40. ZARETSKY DV, Zaretskaia MV, Molkov YI
    Patients with Alzheimer's disease have an increased removal rate of soluble beta-amyloid-42.
    PLoS One. 2022;17:e0276933.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: